2
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Breast Neoplasms
555
Lymphoma
447
Precursor Cell Lymphoblastic Leukemia-Lymphoma
413
Lymphoma, Large B-Cell, Diffuse
348
Leukemia
346
Multiple Myeloma
336
Lymphoma, Non-Hodgkin
317
Leukemia, Myeloid, Acute
289
Leukemia, Lymphocytic, Chronic, B-Cell
286
Lymphoma, Follicular
241
Burkitt Lymphoma
217
Myelodysplastic Syndromes
211
Lymphoma, Mantle-Cell
202
Hodgkin Disease
193
Recurrence
155
Lymphoma, B-Cell, Marginal Zone
142
Melanoma
136
Lymphoma, Large-Cell, Immunoblastic
116
Neoplasms
109
Lymphoma, B-Cell
103
Neuroblastoma
101
Neoplasms, Plasma Cell
99
Ovarian Neoplasms
96
Triple Negative Breast Neoplasms
94
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
91
Myeloproliferative Disorders
87
Hematologic Neoplasms
87
Leukemia, Myeloid, Chronic-Phase
83
Leukemia, Myeloid, Accelerated Phase
80
Leukemia, Myelomonocytic, Chronic
78
Interventions
fludarabine phosphate
1
fludarabine
1
Herpes Zoster Vaccine
1
Cyclophosphamide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Chickenpox
×
Cyclophosphamide
×
Clear all
NCT01953900
2026-04-22
VEGAS
Baylor College of Medicine
Phase 1
Active not recruiting
26 enrolled